Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Nanotechnology Programs at FDA

Nanotechnology Programs at FDA

                        Nanotechnology Guidance Documents
          Nanotechnology Task Force Home
          Science & Research
          Science and Research Special Topics
          Nanotechnology Programs at FDA
          Nanotechnology Task ForceNanotechnology Programs at FDA Nanotechnology Task Force
  
  	
    Share
    Post
    Linkedin

    Email
    PrintAbout the Task Force

The FDA Nanotechnology Task Force (Task Force), formed in August 2006, was charged with determining regulatory approaches that encourage the continued development of innovative, safe, and effective FDA-regulated products that use nanotechnology or nanomaterials. The Task Force also identifies and recommends ways to address any knowledge or policy gaps that exist within the nanotechnology research community. Improved understanding better enables FDA to evaluate possible adverse health effects from FDA-regulated products that use nanotechnology or nanomaterials.

With the gradual increase in nanomaterial-containing product submissions to FDA, the Task Force encourages regulatory science research in nanotechnology through internal research grants. Additionally, the Task Force provides hands-on nanotechnology training to FDA reviewers and research staff to build scientific expertise and capacity. The Task Force members and subject matter experts at FDA also are active in international documentary nanotechnology standards development.

With a dedicated nanotechnology budget, FDA supports the National Nanotechnology Initiative (NNI) and collaborates with other agencies through participation in the Nanoscale Science Engineering and Technology (NSET) subcommittee and the Nanotechnology Environmental and Health Implications (NEHI) working group. FDA provides annual reports towards the President’s Budget supplement request.

The Task Force reports to the Chief Scientist, within the Office of the Commissioner, and its members are designated representatives from all FDA Centers and Offices.

Nanotechnology Task Force Reports

Nanotechnology Task Force Report 2020
	Nanotechnology Task Force Report 2007Press Release

FDA Nanotechnology Report Outlines Scientific, Regulatory Challenges [ARCHIVED]
	FDA Forms Internal Nanotechnology Task Force [ARCHIVED]Public Meetings

FDA NanoDay Virtual Research Symposium, October 9, 2020 (virtual meeting recorded in Adobe Connect)
	FDA Nanotechnology Public Meeting September 8, 2008
	FDA Nanotechnology Public Meeting October 10, 2006

                                                                                  Content current as of:
      02/23/2021Nanotechnology Programs at FDA

          
                        Nanotechnology Guidance Documents
          Nanotechnology Task Force
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop